178 related articles for article (PubMed ID: 25151037)
1. Anti-inflammatory and antinociceptive action of the dimeric enkephalin peptide biphalin in the mouse model of colitis: new potential treatment of abdominal pain associated with inflammatory bowel diseases.
Sobczak M; Pilarczyk A; Jonakowski M; Jarmuż A; Sałaga M; Lipkowski AW; Fichna J
Peptides; 2014 Oct; 60():102-6. PubMed ID: 25151037
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory and antinociceptive action of an orally available nociceptin receptor agonist SCH 221510 in a mouse model of inflammatory bowel diseases.
Sobczak M; Mokrowiecka A; Cygankiewicz AI; Zakrzewski PK; Sałaga M; Storr M; Kordek R; Małecka-Panas E; Krajewska WM; Fichna J
J Pharmacol Exp Ther; 2014 Mar; 348(3):401-9. PubMed ID: 24345466
[TBL] [Abstract][Full Text] [Related]
3. Novel orally available salvinorin A analog PR-38 protects against experimental colitis and reduces abdominal pain in mice by interaction with opioid and cannabinoid receptors.
Sałaga M; Polepally PR; Zakrzewski PK; Cygankiewicz A; Sobczak M; Kordek R; Zjawiony JK; Krajewska WM; Fichna J
Biochem Pharmacol; 2014 Dec; 92(4):618-26. PubMed ID: 25265540
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory action of a novel orally available peptide 317 in mouse models of inflammatory bowel diseases.
Sobczak M; Zakrzewski PK; Cygankiewicz AI; Mokrowiecka A; Chen C; Sałaga M; Małecka-Panas E; Kordek R; Krajewska WM; Fichna J
Pharmacol Rep; 2014 Oct; 66(5):741-50. PubMed ID: 25149976
[TBL] [Abstract][Full Text] [Related]
5. Mixed MOP/DOP agonist biphalin elicits anti-transit effect in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms.
Zielińska M; Jarmuż A; Sałaga M; Lipkowski AW; Fichna J
Pharmacol Rep; 2016 Feb; 68(1):32-6. PubMed ID: 26721348
[TBL] [Abstract][Full Text] [Related]
6. Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome.
Zielińska M; Chen C; Mokrowiecka A; Cygankiewicz AI; Zakrzewski PK; Sałaga M; Małecka-Panas E; Wlaź P; Krajewska WM; Fichna J
J Pharm Pharmacol; 2015 Feb; 67(2):244-54. PubMed ID: 25515402
[TBL] [Abstract][Full Text] [Related]
7. Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors.
Fichna J; Dicay M; Lewellyn K; Janecka A; Zjawiony JK; MacNaughton WK; Storr MA
Inflamm Bowel Dis; 2012 Jun; 18(6):1137-45. PubMed ID: 21953882
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory effect of dual nociceptin and opioid receptor agonist, BU08070, in experimental colitis in mice.
Zielińska M; Ben Haddou T; Cami-Kobeci G; Sałaga M; Jarmuż A; Padysz M; Kordek R; Spetea M; Husbands SM; Fichna J
Eur J Pharmacol; 2015 Oct; 765():582-90. PubMed ID: 26404500
[TBL] [Abstract][Full Text] [Related]
9. The analgesic activity of biphalin and its analog AM 94 in rats.
Leone S; Chiavaroli A; Orlando G; Mollica A; Di Nisio C; Brunetti L; Vacca M
Eur J Pharmacol; 2012 Jun; 685(1-3):70-3. PubMed ID: 22546229
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive profile of biphalin, a dimeric enkephalin analog.
Horan PJ; Mattia A; Bilsky EJ; Weber S; Davis TP; Yamamura HI; Malatynska E; Appleyard SM; Slaninova J; Misicka A
J Pharmacol Exp Ther; 1993 Jun; 265(3):1446-54. PubMed ID: 8389867
[TBL] [Abstract][Full Text] [Related]
11. Biphalin-A Potent Opioid Agonist-As a Panacea for Opioid System-Dependent Pathophysiological Diseases?
Redkiewicz P; Dyniewicz J; Misicka A
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768778
[TBL] [Abstract][Full Text] [Related]
12. Melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice.
Zielińska M; Jarmuż A; Sałaga M; Kordek R; Laudon M; Storr M; Fichna J
Naunyn Schmiedebergs Arch Pharmacol; 2016 May; 389(5):511-9. PubMed ID: 26899972
[TBL] [Abstract][Full Text] [Related]
13. Biphalin preferentially recruits peripheral opioid receptors to facilitate analgesia in a mouse model of cancer pain - A comparison with morphine.
Lesniak A; Bochynska-Czyz M; Sacharczuk M; Benhye S; Misicka A; Bujalska-Zadrozny M; Lipkowski AW
Eur J Pharm Sci; 2016 Jun; 89():39-49. PubMed ID: 27094782
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory and antibacterial effects of human cathelicidin active fragment KR-12 in the mouse models of colitis: a novel potential therapy of inflammatory bowel diseases.
Fabisiak N; Fabisiak A; Chmielowiec-Korzeniowska A; Tymczyna L; Kamysz W; Kordek R; Bauer M; Kamysz E; Fichna J
Pharmacol Rep; 2021 Feb; 73(1):163-171. PubMed ID: 33219923
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive and anti-inflammatory effects of olive oil (Olea europeae L.) in mice.
Eidi A; Moghadam-kia S; Moghadam JZ; Eidi M; Rezazadeh S
Pharm Biol; 2012 Mar; 50(3):332-7. PubMed ID: 22085252
[TBL] [Abstract][Full Text] [Related]
16. Novel mixed NOP/MOP agonist BU08070 alleviates pain and inhibits gastrointestinal motility in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms.
Sobczak M; Cami-Kobeci G; Sałaga M; Husbands SM; Fichna J
Eur J Pharmacol; 2014 Aug; 736():63-9. PubMed ID: 24815321
[TBL] [Abstract][Full Text] [Related]
17. Antinociceptive profile of potent opioid peptide AM94, a fluorinated analogue of biphalin with non-hydrazine linker.
Mollica A; Costante R; Stefanucci A; Pinnen F; Lucente G; Fidanza S; Pieretti S
J Pept Sci; 2013 Apr; 19(4):233-9. PubMed ID: 23136069
[TBL] [Abstract][Full Text] [Related]
18. Pomegranate seed oil nanoemulsions improve the photostability and in vivo antinociceptive effect of a non-steroidal anti-inflammatory drug.
Ferreira LM; Sari MHM; Cervi VF; Gehrcke M; Barbieri AV; Zborowski VA; Beck RCR; Nogueira CW; Cruz L
Colloids Surf B Biointerfaces; 2016 Aug; 144():214-221. PubMed ID: 27088191
[TBL] [Abstract][Full Text] [Related]
19. Molecular assessment of the potential combination therapy of cytokines with biphalin and AZT for Friend leukemia virus infection in vitro.
Tang JL; Lipkowski AW; Specter S
Pharmacol Rep; 2008; 60(2):190-8. PubMed ID: 18443380
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal antinociceptive interaction between the NMDA antagonist ketamine and the opioids, morphine and biphalin.
Kosson D; Klinowiecka A; Kosson P; Bonney I; Carr DB; Mayzner-Zawadzka E; Lipkowski AW
Eur J Pain; 2008 Jul; 12(5):611-6. PubMed ID: 18068383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
